What are the recommended tadalafil doses for adult males with erectile dysfunction and for pulmonary arterial hypertension, and how should the dose be adjusted in hepatic or renal impairment?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Tadalafil Dosing Recommendations

For erectile dysfunction, start with tadalafil 10 mg taken as needed prior to sexual activity, or 2.5 mg once daily for continuous therapy; for pulmonary arterial hypertension, use 40 mg once daily. 1

Erectile Dysfunction Dosing

As-Needed Dosing

  • Starting dose: 10 mg taken prior to anticipated sexual activity 1
  • Titrate based on response: increase to 20 mg or decrease to 5 mg 1
  • Maximum frequency: once per day in most patients 1
  • Effective window: up to 36 hours following dosing 2, 1

The 2018 AUA Guideline strongly recommends dose titration to optimize efficacy 2. Dose titration is essential—work with patients to find the dose that meets treatment expectations without unacceptable adverse effects. 2 Research demonstrates dose-response effects for erectile function improvement 3.

Once-Daily Dosing

  • Starting dose: 2.5 mg taken at approximately the same time daily 1
  • May increase to 5 mg based on efficacy and tolerability 1
  • No timing required relative to sexual activity 1

Once-daily dosing produces equivalent efficacy to on-demand dosing 2. Research shows both 5 mg and 10 mg once-daily regimens significantly improved erectile function, with 84.5-84.6% of patients reporting improved erections 4.

Pulmonary Arterial Hypertension Dosing

The FDA-approved and guideline-recommended dose is 40 mg once daily. 5, 6

The 2014 CHEST Guideline explicitly states: "Treatment with more than the recommended dose of tadalafil (40 mg once daily) has not been studied and is not recommended." 5 The pivotal trial demonstrated that 40 mg significantly improved 6-minute walk distance (33 m placebo-corrected), time to clinical worsening, and quality of life 7. Long-term data supports sustained efficacy at this dose 8.

Pediatric PAH Dosing

  • Starting dose: 0.5-1 mg/kg/day orally 9
  • Maximum dose: 40 mg daily 9
  • Evaluated only in children >3 years of age 9
  • Safety and efficacy data in children are limited 9

Dose Adjustments for Organ Impairment

Renal Impairment

As-Needed Dosing:

  • CrCl 30-50 mL/min: Start with 5 mg, maximum 10 mg once every 48 hours 1
  • CrCl <30 mL/min or hemodialysis: Maximum 5 mg once every 72 hours 1

Once-Daily Dosing:

  • CrCl <30 mL/min or hemodialysis: Not recommended for erectile dysfunction 1
  • CrCl 30-50 mL/min (for BPH/ED): Start with 2.5 mg, may increase to 5 mg 1

The 2018 AUA Guideline advises using PDE5 inhibitors with caution at lower initial doses in renal impairment due to delayed metabolism 2. Research confirms renal insufficiency results in approximately twice the systemic exposure 10.

Hepatic Impairment

As-Needed Dosing:

  • Mild-moderate (Child-Pugh A or B): Maximum 10 mg once per day 1
  • Severe (Child-Pugh C): Not recommended 1

Once-Daily Dosing:

  • Mild-moderate: Use with caution; not extensively evaluated 1
  • Severe: Not recommended 1

The AUA Guideline states PDE5 inhibitors are generally not recommended in severe renal or liver disease 2. Research shows hepatic impairment has negligible effects on tadalafil exposure, but caution remains warranted 10.

Critical Prescribing Considerations

Contraindications

  • Absolute contraindication: Concurrent nitrate use in any form 1, 11
  • Risk of severe hypotension when combined with nitrates 11

Drug Interactions

  • Alpha-blockers: Patients must be stable on alpha-blocker therapy before initiating tadalafil at the lowest dose 1
  • CYP3A4 inhibitors (diltiazem, verapamil): Exercise caution due to increased hypotension risk 11
  • Riociguat: Do not use PDE5 inhibitors for erectile dysfunction in patients on riociguat for PAH due to systemic hypotension risk 5

Patient Education

Incorrect use accounts for a large percentage of treatment failures. 2 Instruct patients that:

  • Sexual stimulation is necessary for erectile dysfunction treatment 2
  • More than one trial may be required to establish efficacy 2
  • Medication can be taken without regard to food 1
  • Large meals may reduce effectiveness 2

Combination Therapy

For erectile dysfunction with testosterone deficiency, tadalafil combined with testosterone therapy is more effective than tadalafil alone 2. However, testosterone is not effective as monotherapy for erectile dysfunction 2.

Common Adverse Effects

Most frequent: headache, dyspepsia, back pain, nasal congestion, myalgia, flushing 2. Tadalafil has the lowest rates of flushing among PDE5 inhibitors 2. Adverse events follow a dose-response pattern 2.

References

Guideline

erectile dysfunction: aua guideline.

The Journal of urology, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.